Cargando…

How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study

BACKGROUND: Missing data are a common problem in prospective studies with a long follow-up, and the volume, pattern and reasons for missing data may be relevant when estimating the cost of illness. We aimed to evaluate the effects of different methods for dealing with missing longitudinal cost data...

Descripción completa

Detalles Bibliográficos
Autores principales: Belger, Mark, Haro, Josep Maria, Reed, Catherine, Happich, Michael, Kahle-Wrobleski, Kristin, Argimon, Josep Maria, Bruno, Giuseppe, Dodel, Richard, Jones, Roy W, Vellas, Bruno, Wimo, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950752/
https://www.ncbi.nlm.nih.gov/pubmed/27430559
http://dx.doi.org/10.1186/s12874-016-0188-1
_version_ 1782443601610932224
author Belger, Mark
Haro, Josep Maria
Reed, Catherine
Happich, Michael
Kahle-Wrobleski, Kristin
Argimon, Josep Maria
Bruno, Giuseppe
Dodel, Richard
Jones, Roy W
Vellas, Bruno
Wimo, Anders
author_facet Belger, Mark
Haro, Josep Maria
Reed, Catherine
Happich, Michael
Kahle-Wrobleski, Kristin
Argimon, Josep Maria
Bruno, Giuseppe
Dodel, Richard
Jones, Roy W
Vellas, Bruno
Wimo, Anders
author_sort Belger, Mark
collection PubMed
description BACKGROUND: Missing data are a common problem in prospective studies with a long follow-up, and the volume, pattern and reasons for missing data may be relevant when estimating the cost of illness. We aimed to evaluate the effects of different methods for dealing with missing longitudinal cost data and for costing caregiver time on total societal costs in Alzheimer’s disease (AD). METHODS: GERAS is an 18-month observational study of costs associated with AD. Total societal costs included patient health and social care costs, and caregiver health and informal care costs. Missing data were classified as missing completely at random (MCAR), missing at random (MAR) or missing not at random (MNAR). Simulation datasets were generated from baseline data with 10–40 % missing total cost data for each missing data mechanism. Datasets were also simulated to reflect the missing cost data pattern at 18 months using MAR and MNAR assumptions. Naïve and multiple imputation (MI) methods were applied to each dataset and results compared with complete GERAS 18-month cost data. Opportunity and replacement cost approaches were used for caregiver time, which was costed with and without supervision included and with time for working caregivers only being costed. RESULTS: Total costs were available for 99.4 % of 1497 patients at baseline. For MCAR datasets, naïve methods performed as well as MI methods. For MAR, MI methods performed better than naïve methods. All imputation approaches were poor for MNAR data. For all approaches, percentage bias increased with missing data volume. For datasets reflecting 18-month patterns, a combination of imputation methods provided more accurate cost estimates (e.g. bias: −1 % vs −6 % for single MI method), although different approaches to costing caregiver time had a greater impact on estimated costs (29–43 % increase over base case estimate). CONCLUSIONS: Methods used to impute missing cost data in AD will impact on accuracy of cost estimates although varying approaches to costing informal caregiver time has the greatest impact on total costs. Tailoring imputation methods to the reason for missing data will further our understanding of the best analytical approach for studies involving cost outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-016-0188-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4950752
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49507522016-07-20 How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study Belger, Mark Haro, Josep Maria Reed, Catherine Happich, Michael Kahle-Wrobleski, Kristin Argimon, Josep Maria Bruno, Giuseppe Dodel, Richard Jones, Roy W Vellas, Bruno Wimo, Anders BMC Med Res Methodol Research Article BACKGROUND: Missing data are a common problem in prospective studies with a long follow-up, and the volume, pattern and reasons for missing data may be relevant when estimating the cost of illness. We aimed to evaluate the effects of different methods for dealing with missing longitudinal cost data and for costing caregiver time on total societal costs in Alzheimer’s disease (AD). METHODS: GERAS is an 18-month observational study of costs associated with AD. Total societal costs included patient health and social care costs, and caregiver health and informal care costs. Missing data were classified as missing completely at random (MCAR), missing at random (MAR) or missing not at random (MNAR). Simulation datasets were generated from baseline data with 10–40 % missing total cost data for each missing data mechanism. Datasets were also simulated to reflect the missing cost data pattern at 18 months using MAR and MNAR assumptions. Naïve and multiple imputation (MI) methods were applied to each dataset and results compared with complete GERAS 18-month cost data. Opportunity and replacement cost approaches were used for caregiver time, which was costed with and without supervision included and with time for working caregivers only being costed. RESULTS: Total costs were available for 99.4 % of 1497 patients at baseline. For MCAR datasets, naïve methods performed as well as MI methods. For MAR, MI methods performed better than naïve methods. All imputation approaches were poor for MNAR data. For all approaches, percentage bias increased with missing data volume. For datasets reflecting 18-month patterns, a combination of imputation methods provided more accurate cost estimates (e.g. bias: −1 % vs −6 % for single MI method), although different approaches to costing caregiver time had a greater impact on estimated costs (29–43 % increase over base case estimate). CONCLUSIONS: Methods used to impute missing cost data in AD will impact on accuracy of cost estimates although varying approaches to costing informal caregiver time has the greatest impact on total costs. Tailoring imputation methods to the reason for missing data will further our understanding of the best analytical approach for studies involving cost outcomes. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12874-016-0188-1) contains supplementary material, which is available to authorized users. BioMed Central 2016-07-18 /pmc/articles/PMC4950752/ /pubmed/27430559 http://dx.doi.org/10.1186/s12874-016-0188-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Belger, Mark
Haro, Josep Maria
Reed, Catherine
Happich, Michael
Kahle-Wrobleski, Kristin
Argimon, Josep Maria
Bruno, Giuseppe
Dodel, Richard
Jones, Roy W
Vellas, Bruno
Wimo, Anders
How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study
title How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study
title_full How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study
title_fullStr How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study
title_full_unstemmed How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study
title_short How to deal with missing longitudinal data in cost of illness analysis in Alzheimer’s disease—suggestions from the GERAS observational study
title_sort how to deal with missing longitudinal data in cost of illness analysis in alzheimer’s disease—suggestions from the geras observational study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950752/
https://www.ncbi.nlm.nih.gov/pubmed/27430559
http://dx.doi.org/10.1186/s12874-016-0188-1
work_keys_str_mv AT belgermark howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy
AT harojosepmaria howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy
AT reedcatherine howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy
AT happichmichael howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy
AT kahlewrobleskikristin howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy
AT argimonjosepmaria howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy
AT brunogiuseppe howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy
AT dodelrichard howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy
AT jonesroyw howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy
AT vellasbruno howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy
AT wimoanders howtodealwithmissinglongitudinaldataincostofillnessanalysisinalzheimersdiseasesuggestionsfromthegerasobservationalstudy